BetaEntity Annotation Prototype

Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed

All extracted treatments

Showing 3,781–3,840 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

local anesthetic infusion1local anesthetic reversal1local anesthetic wound infiltration1local boost1local infiltration anaesthesia1local injections1local radiotherapy1localized thoracic radiotherapy1locoregional treatments1logic-gated Tmod chimeric antigen receptor T-cell therapies1logotherapy1long term haemodialysis1long term treatment1long-term antibiotic therapies1long-term macrolide therapy1long-term non-invasive ventilation1long-term positive pressure ventilation1low anterior resection1low-carbohydrate diet1low-concentrate platelet-rich plasma injections1low-density lipoprotein (LDL)-lowering treatment1low-dose CT1low-dose corticotherapy1low-dose rate brachytherapy1low-dose steroids1low-efficacy therapy1low-field MRI1low-intensity focused ultrasound1low-volume superior trunk block1lower limb strengthening programme1lower limb surgery1lumbar decompression1lumbar sympathetic block1lung protective ventilation strategies1lung resection1lung transplant1lymph node biopsy1lymph node resection1lysine-reduction treatment1maintenance and reliever therapy1maintenance and reliever therapy regimens1maintenance renal replacement therapy1maintenance treatment1major lower limb amputation1major surgery1malaria prophylaxis1management course1mandibular advancement devices1mannose-based diet1manual acupuncture1manual therapies1marital therapy1masculinising chest surgery1mask1masking and retraining therapy1mast cell stabilisation therapy1mastectomies1maxillary nerve block1mechanic trombectomy1mechanical cardiac support1

Articles mentioning treatments

7,227 articles · page 302 of 603
Conventional TherapyLuseogliflozinMAFLDMetabolic Associated Fatty Liver Disease (MAFLD)type 2 diabetes mellitus (T2DM)T2DM

…Biochemical and imaging outcomes at 3,6 monthsLuseogliflozin vs Conventional Therapy – Clinical Outcomes at 3 & 6 MonthsMean ± SD · Between-group P …

Flavonoid supplementationMetabolic dysfunction-associated steatotic liver disease (MASLD)PROSPEROMASLDNAFLDFlavonoidsEmbasePubMed

….47 kg/m2; 95% CI −1.50 to 0.56; p = 0.37; I2 = 0%).Conclusions Flavonoid supplementation may improve hepatocellular injury and insulin resistance in MAS…

endoscopic pancreatic interventionstirzepatidedulaglutidesemaglutidechronic pancreatitistype 2 diabetesChronic pancreatitis (CP)TriNetX US Collaborative Networkendoscopic pancreatic interventionsCP+1 more

…ng celiac plexus block (HR 0.51, 95% CI 0.34–0.78; p=0.001) and endoscopic pancreatic interventions (HR 0.48, 95% CI 0.41–0.56; p<0.001). Furthermore, the risk of …